GALDY Financials: Galderma Group AG AI Analysis



Financials

GALDY Financial

Galderma Group AG

$40.71

3.95%

$1.55

As of today:May 20, 16:55:09 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$39.16

Open

$40.83

Day's Range

$40.55 - $40.94

52 week range

$24.01 - $44.06

Volume

5.1K

Avg.Volume

264.7K

Dividend yield

EPS (TTM)

0.52

Market Cap

$47.7B

What is GALDERMA GROUP AG?

Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug. The company went IPO on 2024-03-22. The Company, through its subsidiaries, operates a portfolio of various self-care brands focusing primarily on dermatological solutions, through its subsidiaries. Products within the portfolio include neuromodulators, fillers, and biostimulators. These products are designed to relax wrinkles via injection, fill wrinkles in a specific location via injection, and stimulate the body's cells to function optimally. The production process for the various products primarily takes place in-house, from research and development to manufacturing. In addition, services including education, scientific engagements, and other services are offered.

Features

Markets

News

Breakdown	TTM	12/31/2025	06/30/2025	12/31/2024	06/30/2024	12/31/2023
Revenue	5,241	2,775	2,466	2,224	2,216	2,101
Revenue Growth (YoY)	18%	25%	11%	6%	10%	--
Cost of Revenue	1,627	871	756	688	667	647
Gross Profit	3,614	1,904	1,710	1,536	1,549	1,453
Selling, General & Admin	2,231	1,141	1,090	932	988	868
Research & Development	245	141	104	125	135	149
Operating Expenses	2,706	1,392	1,314	1,177	1,233	1,130
Other Non Operating Income (Expenses)	-7	2	-9	-2	26	10
Pretax Income	638	386	252	233	77	28
Income Tax Expense	26	-32	58	49	30	89
Net Income	613	419	194	184	47	-61
Net Income Growth	165%	128%	313%	-401.99%	1,075%	--
Shares Outstanding (Diluted)	236.28	236.28	237.7	237.97	237.61	237.56
Shares Change (YoY)	-1%	-1%	0%	0%	0%	--
EPS (Diluted)	2.58	1.77	0.81	0.77	0.19	-0.25
EPS Growth	167%	129%	313%	-400%	1,077%	--
Free Cash Flow	1,031	553	478	255	-42	256
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	68.95%	68.61%	69.34%	69.06%	69.9%	69.15%
Operating Margin	17.32%	18.45%	16.05%	16.14%	14.25%	15.37%
Profit Margin	11.69%	15.09%	7.86%	8.27%	2.12%	-2.9%
Free Cash Flow Margin	19.67%	19.92%	19.38%	11.46%	-1.89%	12.18%
EBITDA	1,231	677	554	510	458	467
EBITDA Margin	23.48%	24.39%	22.46%	22.93%	20.66%	22.22%
D&A For EBITDA	323	165	158	151	142	144
EBIT	908	512	396	359	316	323
EBIT Margin	17.32%	18.45%	16.05%	16.14%	14.25%	15.37%
Effective Tax Rate	4.07%	-8.29%	23.01%	21.03%	38.96%	317.85%

Breakdown

TTM

12/31/2025

06/30/2025

12/31/2024

06/30/2024

12/31/2023

Revenue

5,241

2,775

2,466

2,224

2,216

2,101

Revenue Growth (YoY)

18%

25%

11%

10%

Cost of Revenue

1,627

871

756

688

667

647

Gross Profit

3,614

1,904

1,710

1,536

1,549

1,453

Selling, General & Admin

2,231

1,141

1,090

932

988

868

Research & Development

245

141

104

125

135

149

Operating Expenses

2,706

1,392

1,314

1,177

1,233

1,130

Other Non Operating Income (Expenses)

-7

-9

-2

Pretax Income

638

386

252

233

Income Tax Expense

-32

Net Income

613

419

194

184

-61

Net Income Growth

165%

128%

313%

-401.99%

1,075%

Shares Outstanding (Diluted)

236.28

237.7

237.97

237.61

237.56

Shares Change (YoY)

-1%

EPS (Diluted)

2.58

1.77

0.81

0.77

0.19

-0.25

EPS Growth

167%

129%

313%

-400%

1,077%

Free Cash Flow

1,031

553

478

255

-42

256

Free Cash Flow Per Share

Gross Margin

68.95%

68.61%

69.34%

69.06%

69.9%

69.15%

Operating Margin

17.32%

18.45%

16.05%

16.14%

14.25%

15.37%

Profit Margin

11.69%

15.09%

7.86%

8.27%

2.12%

-2.9%

Free Cash Flow Margin

19.67%

19.92%

19.38%

11.46%

-1.89%

12.18%

EBITDA

1,231

677

554

510

458

467

EBITDA Margin

23.48%

24.39%

22.46%

22.93%

20.66%

22.22%

D&A For EBITDA

323

165

158

151

142

144

EBIT

908

512

396

359

316

323

EBIT Margin

17.32%

18.45%

16.05%

16.14%

14.25%

15.37%

Effective Tax Rate

4.07%

-8.29%

23.01%

21.03%

38.96%

317.85%

Follow-Up Questions

What are Galderma Group AG's key financial statements?



According to the latest financial statement (Form-10K), Galderma Group AG has a total asset of $0, Net loss of $0

What are the key financial ratios for GALDY?



Galderma Group AG's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Galderma Group AG's revenue broken down by segment or geography?



Galderma Group AG largest revenue segment is Other, at a revenue of 35,000,000 in the most earnings release.For geography, USA is the primary market for Galderma Group AG, at a revenue of 2,231,000,000.

Is Galderma Group AG profitable?



no, according to the latest financial statements, Galderma Group AG has a net loss of $0

Does Galderma Group AG have any liabilities?



no, Galderma Group AG has liability of 0

How many outstanding shares for Galderma Group AG?



Galderma Group AG has a total outstanding shares of 0

Galderma Group AG (GALDY) Financial

GALDY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is GALDERMA GROUP AG?

Galderma Group AG (GALDY) Financial

GALDY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is GALDERMA GROUP AG?

GALDY Income

Follow-Up Questions

What are Galderma Group AG's key financial statements?

What are the key financial ratios for GALDY?

How is Galderma Group AG's revenue broken down by segment or geography?

Is Galderma Group AG profitable?

Does Galderma Group AG have any liabilities?

How many outstanding shares for Galderma Group AG?